SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is experiencing a sharp surge in investor interest and bullish momentum following optimistic CEO commentary regarding the survival data of its REGAL Phase 3 clinical trial. The community is actively discussing the potential for an imminent short squeeze and institutional accumulation as they wait for the final 80th trial event, with many retail investors highlighting the immunotherapy platform as a major, de-risked candidate for significant valuation growth.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid intense community polarization, with critics highlighting government settlement news and concerns over financial transparency, while supporters focus on political alignments and upcoming election developments. Investors are actively debating the company's valuation and long-term viability, characterized by high volatility and significant skepticism regarding its ongoing financial performance.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is the central focus of market attention as investors eagerly await earnings results, with the community sharply divided between those betting on a massive breakout driven by relentless AI infrastructure demand and those fearing a potential "sell-the-news" correction. Traders are closely analyzing options volatility and historical post-earnings patterns to navigate the uncertainty, as the stock's performance is widely expected to set the tone for the broader tech sector and the overall market direction.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is surging following a strong quarterly earnings report that featured an earnings beat, raised full-year guidance, and impressive same-store sales growth. The community is actively debating the company's high valuation against its rapid expansion and 'no-discount' strategy, with bulls highlighting its debt-free balance sheet while bears remain skeptical of the stock's premium price-to-earnings multiple.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the FDA's acceptance of their supplemental BLA for ANKTIVA in bladder cancer, with a PDUFA date set for January 6, 2027. Investors are actively discussing this regulatory milestone as a major catalyst that could significantly expand the addressable market for the companys flagship therapy, despite some community frustration over the timeline and ongoing volatility from short sellers.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

Investors are actively debating the long-term growth prospects of e.l.f. Beauty ahead of its upcoming earnings report, weighing the "lipstick effect" and strong brand momentum against concerns over high inflation, tariff impacts, and recent downward price pressure. While some community members view the current volatility as a manipulation-driven "shakeout" that offers a buying opportunity for a resilient consumer staples leader, others remain cautious about potential downward revisions to guidance.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

VanEck Gold Miners ETF (GDX) is trending as it approaches a key support zone between $77 and $82, a level technical analysts are monitoring for a potential reversal in the current corrective decline. The community remains divided, with some traders actively looking for a bullish rebound from these support levels while others are highlighting the increased operational pressure on miners due to rising energy costs.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is currently facing significant volatility as investors weigh the impact of rising Treasury yields and shifting geopolitical tensions against its traditional role as a safe-haven asset. The community is actively debating whether the metal is losing its hedge status to risk-on assets, with many participants analyzing the complex interplay between central bank gold buying, persistent inflation pressures, and the potential for a broader market repricing.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is facing significant market volatility following interim Phase 2 data for its inhaled cystic fibrosis therapy, ARCT-032, which showed biological activity such as mucus plug reduction but failed to demonstrate a statistically significant improvement in lung function. While the company maintains a solid cash position and pipeline diversity with its sa-mRNA platform, investors are expressing frustration over the lack of near-term catalysts and concerns regarding the clinical trial timeline, leading to intense debate about the stock's valuation versus its long-term potential.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

Uranium Energy Corp is attracting intense community attention as traders analyze its production milestones at the Burke Hollow project and strong balance sheet, while positioning for a potential squeeze ahead of growth initiatives. Market participants are actively debating the stock's support levels and its strategic role as a domestic supplier, with many retail investors viewing current volatility as an opportunity to build long-term positions amid the broader nuclear energy renaissance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
